Ten-year trend of rituximab use for hematological malignancies: a multiregional real-world study using the Italian VALORE distributed database network

These findings show a shift from originator to biosimilar rituximab in Italy, alongside a recent decline in its use, likely driven by COVID-19 pandemic and new treatment strategies.

Authors

Institutions

Publication Details

Journal
Expert Opinion on Biological Therapy
Published
2025-10-31
DOI
https://doi.org/10.1080/14712598.2025.2583283
Primary Topic
Biosimilars and Bioanalytical Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ten-year trend of rituximab use for hematological malignancies: a multiregional real-world study using the Italian VALORE distributed database network

Ester Sapigni, Annalisa Campomori, Valeria Belleudi, Luca L’Abbate et al.
Expert Opinion on Biological Therapy
Biosimilars and Bioanalytical Methods
article

Ten-year trend of rituximab use for hematological malignancies: a multiregional real-world study using the Italian VALORE distributed database network

Ester Sapigni, Annalisa Campomori, Valeria Belleudi, Luca L’Abbate, Marco Massari, Aurora Puccini, Martina Zanforlini, Giorgia Pellegrini, Mauro Krampera, Paolo Carta, Anna Cavazzana, Stefania Spila Alegiani, Sara Lopes, Chiara Bellitto, Silvana Anna Maria Urru, Stefano Ledda, Gianluca Trifirò, Ugo Trama, Olivia Leoni, Andrea Spini, Ylenia Ingrasciotta, Lucian Ejlli, Angela Scapin, Paola Rossi, Chiara Alberti, Francesca Futura Bernardi, Paolo Stella, Antea Maria Pia Mangano, Federica Soardo, Francesco Balducci, Anna Paladin, Lorenzo di Spazio
article en

Abstract

These findings show a shift from originator to biosimilar rituximab in Italy, alongside a recent decline in its use, likely driven by COVID-19 pandemic and new treatment strategies.

Expert Opinion on Biological TherapyVol. 25(11)
University of Verona (IT), University of Campania "Luigi Vanvitelli" (IT), Central European Initiative (IT), General Directorate for Environmental Protection (PL), Azienda Ospedaliera Universitaria Integrata Verona (IT), Regional Health (US), Provincia Autonoma di Trento (IT), Agenzia Sanitaria e Sociale Regionale (IT), Regione Puglia (IT), Agenzia Regionale Prevenzione e Ambiente della Regione Emilia-Romagna (IT), Azienda Trasporti Milanesi (Italy) (IT), National Institute of Health (AM), National Observatory (BR), Associazione Regionale Allevatori della Lombardia (IT), Regione del Veneto (IT), Zero Emissions Resource Organisation (NO), Osservatorio Astronomico della Regione Autonoma Valle d'Aosta (IT), Agenzia Regionale di Sanità della Toscana (IT), Servizio Sanitario Nazionale (IT), Regione Emilia-Romagna, Regione Autonoma della Sardegna, Regione Autonoma Friuli Venezia Giulia (IT)
Openalex Percentile: Top 67%
Biosimilars and Bioanalytical Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.